Top Markets
#1 Black Phoenix Black Phoenix +167.81%
#2 Islamic Coin Islamic Coin +158.25%
#3 Glidr Glidr +84.34%
#4 Test Test +25.75%
#5 Cryptopia Cryptopia +21.17%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.42%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +13.36%
#8 Acurast Acurast +13.16%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +10.39%
#10 MarsCoin MarsCoin +9.74%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.

NuGenerex Immuno-Oncology, Inc.

NUGX
Classement en actions #41797
NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating... NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating cancer through the strategic modulation of the immune system. The company's development pipeline includes a range of immunotherapeutic products and vaccines. Notably, it is advancing AE37, a peptide immunotherapeutic vaccine, which is currently undergoing Phase II clinical studies for metastatic triple-negative breast cancer. Founded in 1993 and headquartered in Miramar, Florida, the entity was formerly named Antigen Express, Inc. NuGenerex Immuno-Oncology, Inc. operates as a subsidiary of Generex Biotechnology Corporation.
Prix de l'action
$0.0001
Dernière synchronisation: 2023-05-22
Capitalisation boursière
$10.03K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange NuGenerex Immuno-Oncology, Inc. (NUGX)

Catégorie

Healthcare
Ratio P/B pour NuGenerex Immuno-Oncology, Inc. (NUGX)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de NuGenerex Immuno-Oncology, Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour NuGenerex Immuno-Oncology, Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR